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To the Editor: The birth of a child with Down syndrome (DS) 
has many serious implications – physical and mental deficiencies, 
medical conditions and lifestyle challenges.1 The high incidence (1 in 
600 births in South Africa2) and high cost of medical care highlight 
the need for effective health care.2 The South African Human 
Genetic Policy Guidelines include a rudimentary list pertaining 
to the management of DS.2 In the USA, the American Academy 
of Pediatrics (AAP) has addressed this issue by devising clinical 
protocols3 focusing on improving the level of functioning and 
quality of life of children with DS. Countries such as Thailand4 and, 
to a lesser extent, South Africa, in KwaZulu-Natal,2 have adopted 
and adapted these guidelines. The importance of the guidelines for 
clinical and counselling practices and their routine adherence is a 
daily challenge for 3 Durban hospitals with a total of 2 staff members 
dedicated to genetic matters.
DS studies4,5 have recognised the value of routine screening tests 
and genetic counselling, as they pre-empt the need for targeted 
therapy, early intervention programmes and support groups, which 
results in better quality of health and significant developmental 
progress.
We investigated and compared the clinical management of DS 
children at King Edward VIII, Prince Mshiyeni and Inkosi Albert 
Luthuli Central Hospitals in Durban with that occurring in countries 
such as Thailand, where the guidelines are implemented.4
Method
Medical chart checklists in accordance with AAP guidelines3 (Table 
I) were used to record information from hospital charts (Biomedical 
Research Ethics ref. no. BE100/08), to compare the care received by 
DS children and their families at Durban hospitals with the AAP 
recommendations and that observed in the Thai study.4 The 72 most 
recently treated cases of DS were assessed, and the relevant clinical 
staff facilitated the provision of further patient information including 
observation of routine patient practice in dealing with DS.
The data were captured on a Microsoft Excel spreadsheet, which 
allowed simple derivation of the frequencies of DS in maternal 
age groups, patient age groups, screening tests and counselling 
performed. The frequencies of screening tests conducted and genetic 
counselling services offered were used as a measure of efficiency of 
health care and compared with AAP recommendations and findings 
reported by a study conducted in Thailand.4
Results
Table II shows the standard of clinical care offered to paediatric 
DS patients in this study in terms of screening tests and genetic 
counselling services, and a comparison with that observed in a Thai 
study4 and the AAP recommendations.3 The Thai study did not have 
recorded data for antenatal counselling and support group referrals.
Discussion
Irregularly performed screening tests and minimal genetic counselling 
indicate a need for specific DS guidelines for the strict adherence and 
employment criteria of genetic staff.
The SA guidelines2 on the clinical management of DS offer a 
generalised list rather than a specific protocol. They include points 
addressing advanced maternal age, prenatal and postnatal diagnosis, 
preventive measures, rehabilitation and genetic counselling. Although 
relevant, there are no specific and utilisable clinical protocols on the 
management of DS patients in terms of the types of screening tests, 
preventive measures and rehabilitation. They also lack focus on the 
factors of age groups and development of DS patients.
Our study indicated a significant difference between AAP guidelines 
(Table I), the statistics from the Thai study, and the observed 
frequencies of tests and services offered cumulatively at the three 
Durban hospitals (Table II). While the Thai study adhered to the AAP 
recommendations, the Durban hospitals lagged in both screening 
tests (thyroid function, hearing and vision) and genetic counselling 
services (antenatal and support groups). However, screening tests for 
cardiac defects were performed often (84.7%) owing to their frequent 
occurrence and cause of morbidity and mortality in DS.6
Another concern is the large number of mothers (42.9%) of 
advanced maternal age and low frequency of antenatal counselling 
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Table I. AAP guidelines for management of DS children at 
developmentally significant age groups
Patient age group Clinical focus
Prenatal Genetic counselling on whether to 
continue or terminate pregnancy
Newborn (birth - 1 month) Clinical manifestations, 
developmental progress (eye 
function, feeding, hearing ability), 
support groups, coping methods
Infancy (1 month - 1 year) Screening tests conducted for 
hearing, vision and thyroid 
function and annually thereafter. 
Growth and development is 
monitored
Early childhood (1 - 5 years) Physical, occupational and speech 
therapy. Diet and exercise regimen 
is monitored
Late childhood (5 - 13 years) Physical and sexual development
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observed in the study. Advanced maternal age (a crucial factor in DS, 
illustrated by 80% of births being to mothers >35 years old) should be 
considered in a resource-poor setting such as South Africa.
Regarding genetic staff, there was during the study one full-time 
geneticist, one part-time geneticist, and no genetic counsellors 
employed across the three hospitals – a stark contrast to the 
recommendations made by the Human Genetics Policy of SA which 
prescribes a minimum of 36 genetic counsellors and 18 medical 
geneticists for KZN.2 The subsequent inadequate clinical care of 
DS patients is highlighted in this study and has prompted media 
attention and lawsuits for negligence.7
The provincial and national health departments bear the ultimate 
responsibility for implementing an agreed set of protocols that are 
strictly adhered to, and for employing sufficient genetic staff to 
ensure effective health care for DS patients and their families. Besides 
the financial benefit of a largely preventive health care programme, 
the quality of life of DS patients and their families will increase 
exponentially while alleviating  the strain on the health care system.
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Table II. Comparison of frequencies of screening tests and genetic counselling services offered in this study with AAP recommenda-
tions and a Thai study
Recommended (%) Observed in Thai study (%) Observed in present study (%)
Screening tests
Hearing 100 95 56
Vision 100 94 56
Thyroid function 100 100 18.1
Cardiac defects 100 100 84.7
Genetic counselling services
Antenatal counselling 100 11.1
Postnatal counselling 100 100 84.7
Referral to support group 100 27.8
p<0.5; statistically not significant.
